Tectonic Therapeutic, Inc. financial data

Symbol
TECX on Nasdaq
Location
Watertown, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2576% % 156%
Debt-to-equity 4% % -77%
Return On Equity -27% % 59%
Return On Assets -26% % 32%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18,776,626 shares 0.61%
Common Stock, Shares, Outstanding 18,738,249 shares 26%
Entity Public Float $232,000,000 USD 102%
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 18,322,533 shares 116%
Weighted Average Number of Shares Outstanding, Diluted 18,322,533 shares 116%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $63,489,000 USD 53%
General and Administrative Expense $20,547,000 USD 23%
Costs and Expenses $3,240,000 USD -3.3%
Operating Income (Loss) $84,036,000 USD -45%
Nonoperating Income (Expense) $11,115,000 USD 33582%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $19,035,000 USD -7.4%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $74,151,000 USD -28%
Earnings Per Share, Basic -4.05 USD/shares 41%
Earnings Per Share, Diluted -4.05 USD/shares 41%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $253,798,000 USD 80%
Other Assets, Current $626,000 USD -26%
Assets, Current $257,359,000 USD 75%
Property, Plant and Equipment, Net $1,185,000 USD -45%
Operating Lease, Right-of-Use Asset $874,000 USD -61%
Other Assets, Noncurrent $640,000 USD 310%
Assets $261,038,000 USD 71%
Accounts Payable, Current $1,093,000 USD 12%
Employee-related Liabilities, Current $3,106,000 USD 29%
Accrued Liabilities, Current $7,340,000 USD -6.5%
Liabilities, Current $9,666,000 USD -17%
Operating Lease, Liability, Noncurrent $0 USD -100%
Liabilities $9,709,000 USD -20%
Accumulated Other Comprehensive Income (Loss), Net of Tax $96,000 USD -1167%
Retained Earnings (Accumulated Deficit) $222,737,000 USD -50%
Stockholders' Equity Attributable to Parent $251,329,000 USD 79%
Liabilities and Equity $261,038,000 USD 71%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $13,083,000 USD -41%
Net Cash Provided by (Used in) Financing Activities $178,122,000 USD
Net Cash Provided by (Used in) Investing Activities $27,000 USD -575%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 18,738,249 shares 26%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $165,007,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $254,870,000 USD 80%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $188,891,000 USD 11%
Deferred Tax Assets, Gross $189,521,000 USD 11%
Operating Lease, Liability $889,000 USD -63%
Depreciation $281,000 USD 10%
Payments to Acquire Property, Plant, and Equipment $27,000 USD 575%
Lessee, Operating Lease, Liability, to be Paid $948,000 USD -62%
Property, Plant and Equipment, Gross $4,592,000 USD -6.2%
Operating Lease, Liability, Current $889,000 USD -61%
Lessee, Operating Lease, Liability, to be Paid, Year Two $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One $948,000 USD -60%
Operating Lease, Weighted Average Discount Rate, Percent 0.0086 pure -19%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $59,000 USD -42%
Lessee, Operating Lease, Liability, to be Paid, Year Three $0 USD
Deferred Tax Assets, Operating Loss Carryforwards $123,867,000 USD 13%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Operating Lease, Payments $5,300,000 USD
Additional Paid in Capital $474,160,000 USD 64%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $360,000 USD -4.5%
Deferred Tax Assets, Net of Valuation Allowance $630,000 USD -42%
Share-based Payment Arrangement, Expense $10,497,000 USD 201%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%